BACKGROUND: Changes in sexual risk behaviour may occur following HIV-1 infection. OBJECTIVE: To test the hypothesis that HIV-1 seroconversion and disease progression are associated with changes in risk behaviours, using data from a cohort of Kenyan female sex workers (FSWs). METHODS: HIV-1-seronegative FSWs were enrolled in a prospective cohort study of risk factors for HIV-1 acquisition. At monthly visits, standardized interviews were conducted to assess sexual risk behaviour and HIV-1 serologic testing was performed. Seroconverters were invited to continue with follow-up. Between 1993 and 2004 (when antiretroviral therapy was introduced in the cohort), 265 women seroconverted for HIV-1 (incidence 7.7/100 person-years) and were included in this analysis. RESULTS: Unprotected intercourse was reported at 546/2037 (27%) pre-seroconversion visits versus 557/3732 (15%) post-seroconversion visits (P < 0.001). These findings remained significant after adjustment for potential confounding factors [adjusted odds ratio (AOR) 0.69; 95% confidence interval (CI), 0.55-0.86]. Compared with HIV-1-seronegative women, there was a progressive stepwise decrease in unprotected intercourse among HIV-1-seropositive women with CD4 cell counts > or = 500 (AOR, 0.93; 95% CI, 0.62-1.39), 200-499 (AOR, 0.58; 95% CI, 0.41-0.82) and < 200 cells/microl (AOR, 0.45; 95% CI, 0.25-0.82). Decreases in unprotected intercourse reflected increases in both abstinence and 100% condom use. Women also reported fewer partners and fewer episodes of intercourse after HIV-1 seroconversion. CONCLUSIONS: HIV-1 seroconversion and disease progression were associated with decreases in sexual risk behaviour among Kenyan FSWs.
BACKGROUND: Changes in sexual risk behaviour may occur following HIV-1 infection. OBJECTIVE: To test the hypothesis that HIV-1 seroconversion and disease progression are associated with changes in risk behaviours, using data from a cohort of Kenyan female sex workers (FSWs). METHODS:HIV-1-seronegative FSWs were enrolled in a prospective cohort study of risk factors for HIV-1 acquisition. At monthly visits, standardized interviews were conducted to assess sexual risk behaviour and HIV-1 serologic testing was performed. Seroconverters were invited to continue with follow-up. Between 1993 and 2004 (when antiretroviral therapy was introduced in the cohort), 265 women seroconverted for HIV-1 (incidence 7.7/100 person-years) and were included in this analysis. RESULTS: Unprotected intercourse was reported at 546/2037 (27%) pre-seroconversion visits versus 557/3732 (15%) post-seroconversion visits (P < 0.001). These findings remained significant after adjustment for potential confounding factors [adjusted odds ratio (AOR) 0.69; 95% confidence interval (CI), 0.55-0.86]. Compared with HIV-1-seronegative women, there was a progressive stepwise decrease in unprotected intercourse among HIV-1-seropositivewomen with CD4 cell counts > or = 500 (AOR, 0.93; 95% CI, 0.62-1.39), 200-499 (AOR, 0.58; 95% CI, 0.41-0.82) and < 200 cells/microl (AOR, 0.45; 95% CI, 0.25-0.82). Decreases in unprotected intercourse reflected increases in both abstinence and 100% condom use. Women also reported fewer partners and fewer episodes of intercourse after HIV-1 seroconversion. CONCLUSIONS:HIV-1 seroconversion and disease progression were associated with decreases in sexual risk behaviour among Kenyan FSWs.
Authors: Darcy White; Kate S Wilson; Linnet N Masese; George Wanje; Walter Jaoko; Kishorchandra Mandaliya; Barbra A Richardson; John Kinuthia; Jane M Simoni; R Scott McClelland Journal: Sex Transm Dis Date: 2016-10 Impact factor: 2.830
Authors: R Scott McClelland; Susan M Graham; Barbra A Richardson; Norbert Peshu; Linnet N Masese; George H Wanje; Kishorchandra N Mandaliya; Ann E Kurth; Walter Jaoko; Jeckoniah O Ndinya-Achola Journal: AIDS Date: 2010-03-27 Impact factor: 4.177
Authors: R Scott McClelland; Barbra A Richardson; George H Wanje; Susan M Graham; Esther Mutunga; Norbert Peshu; James N Kiarie; Ann E Kurth; Walter Jaoko Journal: Sex Transm Dis Date: 2011-05 Impact factor: 2.830
Authors: Andrew D Redd; Caroline E Mullis; David Serwadda; Xiangrong Kong; Craig Martens; Stacy M Ricklefs; Aaron A R Tobian; Changchang Xiao; Mary K Grabowski; Fred Nalugoda; Godfrey Kigozi; Oliver Laeyendecker; Joseph Kagaayi; Nelson Sewankambo; Ronald H Gray; Stephen F Porcella; Maria J Wawer; Thomas C Quinn Journal: J Infect Dis Date: 2012-06-05 Impact factor: 5.226
Authors: Susan M Graham; Linnet Masese; Ruth Gitau; Dickson Mwakangalu; Walter Jaoko; Jeckoniah Ndinya-Achola; Kishor Mandaliya; Norbert Peshu; Jared M Baeten; R Scott McClelland Journal: J Acquir Immune Defic Syndr Date: 2009-12 Impact factor: 3.731
Authors: Matthew F Chersich; Stanley Luchters; Innocent Ntaganira; Antonio Gerbase; Ying-Ru Lo; Fiona Scorgie; Richard Steen Journal: J Int AIDS Soc Date: 2013-03-04 Impact factor: 5.396